Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 7,766 shares at $256.99 ($2.0M) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Scheduled sale ($2.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.99 | 3,883 | $998K | 50.0% |
| 2 | $256.99 | 3,883 | $998K | 50.0% |
| Total | $256.99 avg | 7,766 | $2.0M | 100% |
| Filing → |
| RMD | SELL | 2026-02-03 | $257K | — | Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |